Cannabis Health/LinkedIn
Mar 9, 2026, 10:16
Ananda Pharma Cleared to Launch Phase 2 Trial for Endometriosis Pain Treatment – Cannabis Health
Cannabis Health shared a post on LinkedIn:
“Ananda Pharma Ltd has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial in women with endometriosis-associated pain.
The company has received approval from the MHRA and NHS Health Research Authority to commence dosing of its proprietary MRX1 CBD oral solution.
Melissa Sturgess, CEO of Ananda Pharma, said: ‘The reason this study is different is that we are using a product that could go all the way through to regulatory approval and be able to be prescribed by a doctor on the NHS.’ ”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 9, 2026, 10:37Vicki Hodges: I’m on My Way to the Nexus Connected Endometriosis Event
-
Mar 9, 2026, 09:52Sheila Ann Mikhail: Women’s Health Advocates Convene on Capitol Hill to Discuss Endometriosis
-
Mar 9, 2026, 09:40Does Surgery Reduce Iron Deposition in Ovarian Endometriomas? – RBMO
-
Mar 9, 2026, 09:29Role of the Oocyte Cortical Domain in Maturation and Fertilisation – ESHRE
-
Mar 9, 2026, 09:22The Impact of Physical Activity and Stress on Frozen Embryo Transfer – Fertility and Sterility
-
Mar 9, 2026, 07:57Preeclampsia Foundation Highlights Warning Signs of Preeclampsia in Pregnancy
-
Mar 8, 2026, 06:03New Study Links TyG-BMI to Miscarriage Risk in IVF Patients – Fertility and Sterility
-
Mar 8, 2026, 05:48Study Invites Pakistani and Bangladeshi Mothers Pregnant After Baby Loss – Miscarriage Association
-
Mar 8, 2026, 05:24Comprehensive Look at Women’s Health Through Yale Medicine Magazine – Yale Obstetrics, Gynecology and Reproductive Sciences